David Dingli, M.D., Ph.D., with Hematology at Mayo Clinic's campus in Rochester, Minnesota, discusses findings from the study Therapy for Relapsed Multiple Myeloma: Guidelines From the Mayo Stratification for Myeloma and Risk-Adapted Therapy, which was published in the April 2017 issue of Mayo Clinic Proceedings.
Dr. Dingli updates clinicians and patients on new treatment options for this increasingly complicated disease progression.
Related Presenters
